This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2001 May 18;84(10):1289-90.

doi: 10.1054/bjoc.2001.1797.

Flasks, fibres and flanks--pre-clinical tumour models for predicting clinical antitumour activity

PMID: 11355935
PMCID: PMC2363634
DOI: 10.1054/bjoc.2001.1797

Free PMC article

Editorial

Flasks, fibres and flanks--pre-clinical tumour models for predicting clinical antitumour activity

D R Newell. Br J Cancer. 2001.

Free PMC article

. 2001 May 18;84(10):1289-90.

doi: 10.1054/bjoc.2001.1797.

Author

PMID: 11355935
PMCID: PMC2363634
DOI: 10.1054/bjoc.2001.1797

No abstract available

PubMed Disclaimer

Comment on

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials.
Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M, Arbuck S, Hollingshead M, Sausville EA. Johnson JI, et al. Br J Cancer. 2001 May 18;84(10):1424-31. doi: 10.1054/bjoc.2001.1796. Br J Cancer. 2001. PMID: 11355958 Free PMC article.

Similar articles

[New approaches in experimental cancerology: in search of therapeutic models].
Guilbaud N, Kraus-Berthier L, Meyer-Losic F, Pierré A, Hickman J. Guilbaud N, et al. Bull Cancer. 2001 Jan;88(1):75-84. Bull Cancer. 2001. PMID: 11182656 French. No abstract available.
[In vitro systems for the primary search for biologically active substances with carcinostatic action].
Egorov LV, Chernov VA, Sokolova AS. Egorov LV, et al. Eksp Onkol. 1988;10(4):11-7. Eksp Onkol. 1988. PMID: 3053148 Review. Russian.
Clinical development of anticancer agents--a National Cancer Institute perspective.
Marsoni S, Wittes R. Marsoni S, et al. Cancer Treat Rep. 1984 Jan;68(1):77-85. Cancer Treat Rep. 1984. PMID: 6362870 Clinical Trial. No abstract available.
[Antitumor drug screening at the National Cancer Institute, U.S.A].
Tsuruo T. Tsuruo T. Gan To Kagaku Ryoho. 1987 Oct;14(10):2809-15. Gan To Kagaku Ryoho. 1987. PMID: 3310904 Review. Japanese.
The role of the National Cancer Institute in drug development.
Doroshow J. Doroshow J. Clin Adv Hematol Oncol. 2005 Apr;3(4):257-8. Clin Adv Hematol Oncol. 2005. PMID: 16166997 No abstract available.

See all similar articles

Cited by

Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN-ALK Fusion In Vitro.
Ferrari SM, Ragusa F, Elia G, Mazzi V, Balestri E, Botrini C, Rugani L, Patrizio A, Piaggi S, La Motta C, Ulisse S, Virili C, Antonelli A, Fallahi P. Ferrari SM, et al. Int J Mol Sci. 2024 Jun 19;25(12):6734. doi: 10.3390/ijms25126734. Int J Mol Sci. 2024. PMID: 38928438 Free PMC article.
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture.
Ferrari SM, Elia G, Ragusa F, Paparo SR, Mazzi V, Patrizio A, Piaggi S, Baldini E, Centanni M, La Motta C, Antonelli A, Fallahi P. Ferrari SM, et al. Int J Mol Sci. 2023 Jan 25;24(3):2398. doi: 10.3390/ijms24032398. Int J Mol Sci. 2023. PMID: 36768721 Free PMC article.
VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid Cancer.
Chen S, Su X, Jiang X, Zhang T, Min I, Ding Y, Wang X, Mao Z, Cao J, Teng X, Fahey TJ 3rd, Wang W, Teng L. Chen S, et al. Transl Oncol. 2020 Feb;13(2):441-451. doi: 10.1016/j.tranon.2019.10.007. Epub 2020 Jan 3. Transl Oncol. 2020. PMID: 31911278 Free PMC article.
Nanomedicine mediated thyroid cancer diagnosis and treatment: an approach from generalized to personalized medicine.
Gulwani D, Upadhyay P, Goel R, Sarangthem V, Singh TD. Gulwani D, et al. Discov Oncol. 2024 Dec 18;15(1):789. doi: 10.1007/s12672-024-01677-8. Discov Oncol. 2024. PMID: 39692930 Free PMC article. Review.
Antibody Drug Conjugates: Preclinical Considerations.
Bornstein GG. Bornstein GG. AAPS J. 2015 May;17(3):525-34. doi: 10.1208/s12248-015-9738-4. Epub 2015 Feb 28. AAPS J. 2015. PMID: 25724883 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database